Yes, You Can Get an ADHD Diagnosis Through a Video Call. Here Is What That Actually Means.

"Can you actually diagnose ADHD through a video call?"

I get this question regularly. From people who are considering an evaluation, from people who have already been through one, and from people who have been told by someone else that telehealth ADHD care is not legitimate.

The short answer is yes. The longer answer, including a regulatory situation that is genuinely unsettled, is worth understanding.

Telehealth ADHD Care Is Legal and Clinically Valid in Washington State

Washington State has some of the more forward thinking telehealth laws in the country. A telehealth visit carries the same legal and clinical weight as an in person visit for establishing a provider patient relationship, making diagnoses, and prescribing medications.

Stimulant medications can currently be prescribed via telehealth. Under federal rules in effect now, Schedule II medications such as amphetamine salts and methylphenidate can be prescribed following a thorough telehealth evaluation, without a prior in person visit. The requirements are otherwise the same as in person care: a complete clinical assessment, verification through the Washington State Prescription Monitoring Program, and electronic prescribing.

The Part Most Articles Leave Out

The federal permission described above is temporary, and has been temporary for years.

The flexibilities that allow controlled substances to be prescribed via telemedicine without a prior in person evaluation began as a COVID-19 measure. They have since been extended four times. The current extension runs through December 31, 2026.

The DEA proposed a permanent framework in January 2025, built around special registrations for telemedicine prescribing. That proposal has not been finalized. The agencies have said they intend to issue final rules before the current extension lapses.

What that means practically: telehealth stimulant prescribing is legal today, the rules governing it in 2027 are not yet written, and anyone telling you confidently what happens next is guessing.

This is worth knowing before you start care with any telehealth ADHD provider, including this one. The reasonable question to ask is not whether a practice is compliant today. It is what the practice plans to do if the rules change, whether there is a pathway to an in person evaluation if one becomes required, and whether the provider has working familiarity with non-stimulant options that are not affected by controlled substance rules at all.

What a Telehealth ADHD Evaluation Actually Involves

A legitimate telehealth ADHD evaluation is not a ten minute questionnaire followed by a prescription. It is a clinical interview, typically sixty minutes or longer for an initial evaluation, covering current symptoms, developmental history, functional impairment across multiple settings, psychiatric history, medical history, family history, substance use, and the differential diagnosis.

That last item does most of the work. Adult ADHD shares surface features with several other conditions, and distinguishing it from bipolar disorder, from anxiety, and from the compensatory patterns that can resemble OCD is a substantial part of the evaluation rather than a formality at the end of it.

Validated rating scales are administered and reviewed. Collateral information is considered where available. The clinical picture is built over time, including how the patient responds to treatment, what changes, and what does not.

The core tools of ADHD evaluation translate well to video. A clinical interview is a clinical interview regardless of whether it happens across a desk or across a screen. Validated questionnaires are completed before the appointment. Objective testing, when indicated, can be conducted remotely as well.

What telehealth cannot provide is a physical examination. For most ADHD evaluations this is not the limitation it sounds like, because ADHD is not diagnosed through physical findings. It does matter in specific situations: baseline vital signs before starting a stimulant, for instance, or a cardiac history that warrants examination. Those situations call for coordination with a primary care provider rather than for abandoning telehealth.

Why Telehealth Is Particularly Well Suited to ADHD Care

There is something worth noting about who ADHD telehealth serves, and why.

One of the hallmarks of ADHD is difficulty with time management, transitions, and follow through on appointments. The practical barriers to in person psychiatric care, such as finding a provider with availability, driving across town, sitting in a waiting room, and navigating the transition back to work afterward, are not small barriers for someone whose nervous system already struggles with exactly those things.

Telehealth removes several of them. The appointment happens from wherever the patient is. There is no commute, no waiting room, and the transition back to work is about thirty seconds.

Attendance data supports the general point. A 2025 systematic review and meta-analysis pooled 45 cohort studies comparing virtual and in person models and found meaningfully lower odds of non-attendance with virtual care.¹ The authors described the effect as moderate, and noted substantial variation between studies.

I want to be careful not to overstate this. That meta-analysis was across all of healthcare, not ADHD specifically, and it cannot separate the effect of the modality from the effect of who chooses it. ADHD-specific attendance data exists but is thinner. The claim I am comfortable making is that telehealth removes barriers that are unusually relevant in ADHD, and that the general attendance literature is consistent with that.

This matters for outcomes. Consistent follow up is what makes ADHD care work. Medication titration requires regular contact, and a medication that quietly stopped working only gets caught if someone is checking. A care model that makes that contact easier is not a compromise.

Availability matters for a particular group of people: those who already have a diagnosis and have just lost the prescriber who was managing it. A video appointment is usually the fastest route back into care, and transferring an existing ADHD prescription follows a different path from a first evaluation.

A Note on Quality

Not all telehealth ADHD care is the same. The legitimacy of the modality does not guarantee the quality of the evaluation. A rushed evaluation is a rushed evaluation whether it happens on video or in person. A thoughtful, thorough evaluation is also a thorough evaluation regardless of where it happens.

The right question is not whether telehealth ADHD care is legitimate. It is whether the specific provider doing the evaluation is taking the time to do it properly, and what their plan is when the regulatory ground shifts under all of us at the end of this year.

The guide to adult ADHD covers what a full evaluation involves, how the diagnosis is actually made, and where the current Washington and federal rules sit.

Those questions are worth asking of any provider, anywhere.

Reference
1. Greenup EP, Best D. Systematic review and meta-analysis of no show or non-attendance rates among telehealth and in-person models of care. BMC Health Services Research. 2025;25(1):663. doi:10.1186/s12913-025-12826-2

Diagnosis is only the first half. Online ADHD medication management in Washington is what ongoing telehealth prescribing actually looks like after that first evaluation.

The content on this website is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.